September 8, 2017 / 11:26 PM / 10 months ago

8th Circuit revives whistleblower claims over Baycol marketing

A federal appeals court on Friday revived a lawsuit accusing Bayer Healthcare of fraudulently inducing the U.S. Defense Department to buy the cholesterol-fighting drug Baycol by overstating its effectiveness and downplaying the risk that it could cause muscle damage.

A split panel of the 8th U.S. Circuit Court of Appeals overturned the dismissal of former Bayer employee Laurie Simpson’s lawsuit, saying a federal judge in Minnesota applied the wrong standard in determining whether she was the “original source” of the information as required by the False Claims Act.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below